A major clinical trial shows that an inflammatory drug called colchicine is effective in treating Covid-19 and reduces the risk of complications from the disease, doctors in Canada said.
The results of the study are a “major scientific discovery” and make colchicine — a medicine used to treat gout — “the world’s first oral drug that could be used to treat non-hospitalized patients with Covid-19,” the Montreal Heart Institute said in a statement late Friday.
The study results show that colchicine reduced by 21 percent the risk of death or hospitalizations in patients with Covid-19 compared to placebo, the institute said.
The study was carried out in Canada, the US, Europe, and South America among a population of 4,488 patients.
In 4,159 of these patients, in whom the diagnosis of Covid-19 was proven by a nasopharyngeal PCR test, use of colchicine reduced hospitalizations by 25 percent, the need for mechanical ventilation by 50 percent, and deaths by 44 percent, the study…
Source: Guardian Newspaper